Jonathan Gallego-Rudolf

McGill University
Montreal, Canada

PAPER Langella S, Bonta K, Chen Y, Su Y, Vasquez D, Aguillon D, Acosta-Baena N, Baena AY, Garcia-Ospina G, Giraldo-Chica M, Tirado V, Muñoz C, Ríos-Romenets S, Guzman-Martínez C, Pruzin JJ, Ghisays V, Arboleda-Velasquez JF, Kosik KS, Tariot PN, Reiman EM, Lopera F, Quiroz YT

Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease.

Alzheimers Res Ther. 2024 Oct 1;16(1):208. PubMed.

Paula Chilton

University of Louisville
Louisville, United States

Ivan Manuel

Martina Chiacchiaretta

Italy

Rebecca Marvil

Houston, United States

Andrea Pfeifer on A Country Doctor, But Oh So Much More: Francisco Lopera, 73

COMMENT I was extremely saddened by the news that Francisco had passed away. I recall us saying goodbye to each other at the AAIC meeting in Philadelphia only a few weeks ago. He was such a magnificent inspiration to anyone working in the field of Alzheimer’s dis

Marc Aurel Busche on Synaptic Skirmish: Aβ and Tau Pathologies Battle Over Brain Rhythms

COMMENT This study provides important evidence supporting a biphasic neurophysiological model of Alzheimer’s disease (AD) progression, as previously proposed by Harris et al., 2020. Several studies from multiple laboratories have established a clear sequence in m

Heather Eames

Trinity College Dublin
Ireland

PAPER Frey L, Zhou J, Cereghetti G, Weber ME, Rhyner D, Pokharna A, Wenchel L, Kadavath H, Cao Y, Meier BH, Peter M, Greenwald J, Riek R, Mezzenga R

A structural rationale for reversible vs irreversible amyloid fibril formation from a single protein.

Nat Commun. 2024 Sep 30;15(1):8448. PubMed.

PAPER Vaziri Y

Thе Mеditеrranеan Diеt: A Powеrful Dеfеnsе Against Alzhеimеr Disease-A Comprеhеnsivе Rеviеw.

Clin Nutr ESPEN. 2024 Sep 28; PubMed.

Rebecca Kelly

Rui Zhong

United States

Brittani Evans

Banner Research

Michael Belloy on X-Chromosome-Wide Association Data Spot Alzheimer’s Loci

COMMENT After decades of the X chromosome remaining in the dark, it is wonderful now to have, in addition to ours, two additional Alzheimer’s disease XWAS papers see the light of day (Le Borgne et al., 2024; Simmonds et al., 2024). I believe this corroborates the